These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6432417)

  • 1. Auranofin and D-penicillamine: a one year comparative study of safety and efficacy in patients with rheumatoid arthritis followed by a two year open assessment of auranofin.
    Franchimont P; Hauwaert C; Vanschoubroek K
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():75-82. PubMed ID: 6432417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Auranofin versus penicillamine in rheumatoid arthritis. One-year results from a prospective clinical investigation.
    Manthorpe R; Hørbov S; Sylvest J; Vinterberg H
    Scand J Rheumatol; 1986; 15(1):13-22. PubMed ID: 3083505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 12-month comparative trial of auranofin and D-penicillamine in rheumatoid arthritis.
    Felix-Davies DD; Stewart AM; Wilkinson BR; Bateman JR; Delamere JP
    Am J Med; 1983 Dec; 75(6A):138-41. PubMed ID: 6419596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An European open multicentre trial with auranofin in rheumatoid arthritis.
    Raeman F; Hanssens F; Delattre M
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():33-8. PubMed ID: 6432411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multicenter double-blind comparison of auranofin and Tauredon].
    Kaik B; Bröll H
    Wien Klin Wochenschr Suppl; 1984; 156():33-40. PubMed ID: 6442055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Auranofin or D-penicillamine in the treatment of rheumatoid arthritis.
    Hochberg MC
    Ann Intern Med; 1986 Oct; 105(4):528-35. PubMed ID: 3092712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Auranofin versus placebo in the treatment of rheumatoid arthritis.
    Wenger ME; Alexander S; Bland JH; Blechman WJ
    Am J Med; 1983 Dec; 75(6A):123-7. PubMed ID: 6419593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of auranofin and aurothioglucose in the treatment of rheumatoid arthritis: a single blind study.
    van Riel PL; van de Putte LB; Gribnau FW; Macrae KD
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():51-6. PubMed ID: 6432414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
    J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preliminary results of oral gold treatment with auranofin following lack of success of intramuscular gold therapy].
    Rainer F; Ulreich A
    Wien Klin Wochenschr Suppl; 1984; 156():49-51. PubMed ID: 6442058
    [No Abstract]   [Full Text] [Related]  

  • 11. [Auranofin in the treatment of chronic polyarthritis. Results of an open multicenter study].
    Siegmeth W
    Wien Klin Wochenschr Suppl; 1984; 156():27-33. PubMed ID: 6442053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single-blind comparative study of auranofin and hydroxychloroquine in patients with rheumatoid arthritis.
    Bird HA; Le Gallez P; Dixon JS; Surrall KE; Cole DS; Goldman MH; Wright V
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():57-66. PubMed ID: 6432415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
    Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
    Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral gold therapy with auranofin (SK&F 39162). A multicenter open study in patients with rheumatoid arthritis.
    Bandilla K; Gross D; Gross W; Herrlinger JD; Kriegel W; Müller W; Siegmeth W; Tausch G; Thumb N; Wagenhäuser FJ
    J Rheumatol Suppl; 1982; 8():154-9. PubMed ID: 6813478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.
    Chaffman M; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 May; 27(5):378-424. PubMed ID: 6426923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in mononuclear cell function in patients with rheumatoid arthritis following treatment with auranofin.
    Coughlan RJ; Richter MB; Panayi GS
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():25-32. PubMed ID: 6432410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial.
    Ward JR; Williams HJ; Egger MJ; Reading JC; Boyce E; Altz-Smith M; Samuelson CO; Willkens RF; Solsky MA; Hayes SP
    Arthritis Rheum; 1983 Nov; 26(11):1303-15. PubMed ID: 6416259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longterm experience with oral gold in rheumatoid arthritis and psoriatic arthritis.
    Dequeker J; Verdickt W; Gevers G; Vanschoubroek K
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():67-74. PubMed ID: 6432416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early experiences with auranofin in juvenile rheumatoid arthritis.
    Brewer EJ; Giannini EH; Person DA
    Am J Med; 1983 Dec; 75(6A):152-6. PubMed ID: 6419599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gold levels produced by treatment with auranofin and sodium aurothiomalate.
    Lewis D; Capell HA; McNeil CJ; Iqbal MS; Brown DH; Smith WE
    Ann Rheum Dis; 1983 Oct; 42(5):566-70. PubMed ID: 6414387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.